Introduction
At birth, a pair of human ovaries contain 1-2 million primordial follicles arrested at the primordial stage of development (Block, 1953; Baker, 1963) and there is no possibility of addition or replacement afterwards since oogonial stem cells have disappeared. Throughout infancy, childhood and adolescence, and continuing throughout the reproductive years, this endowment is progressively depleted as individual follicles exit the pool and folliculogenesis begins (Gosden, 1985) . Theoretically, every primordial follicle has the potential to mature, secrete oestrogen and ovulate. However, until puberty, blood concentrations of follicle stimulating hormone (FSH) and luteinizing hormone (LH) remain too low to stimulate full preovulatory follicular development. When menstrual cycles begin, cyclic increases in pituitary FSH secretion rescue multiple follicles from atresia and propel them to further development. In each cycle, one such follicle assumes dominance, secretes oestrogen and ovulates, while others become atretic (Gougeon, 1982) . Selection of the dominant follicle can be explained by developmentrelated changes in responsiveness to FSH and LH, which occur in granulosa and theca cells modulated by ovarian para(auto)crine mechanisms (Hillier, 1991a,b) . This review summarizes the process of folliculogenesis and examines the possibility of applying in-vitro maturation to generate meiotically competent oocytes.
Folliculogenesis
The development of the human ovarian follicle, which culminates with the production of a single dominant follicle during each menstrual cycle, occurs as a result of three successive steps: (i) recruitment (the initiation of primordial follicle growth furnishing the ovaries with a new cohort of developing follicles); (ii) basal follicular growth; Johnson and Everitt, 1990.) and (iii) selection and maturation of the preovulatory follicle.
Recruitment
Three types of non-growing follicles have been defined (Lintern-Moore et al., 1974; Gougeon and Chainy, 1987) : (i) primordial follicles, in which the oocyte is surrounded by flattened granulosa cells (GC) ( Figure 1) ; (ii) intermediary follicles, in which the oocyte is surrounded by a mixture of flattened and cuboidal GC; and (iii) primary follicles, in which the oocyte is surrounded by a single layer of cuboidal GC. Primordial, intermediary and primary follicles differ in diameter, but not in the mean diameter of their oocyte and germinal vesicle. Consequently, the transition from the primordial to the primary follicular stage is not a growing but rather a very slow maturation process (Gougeon and Chainy, 1987) . Oocytes enter meiosis during fetal life, but nuclear development progresses no further than diplotene until they begin to ripen cyclically in the Graafian follicles of adult ovaries.
Follicle growth is a continuous process occurring throughout the reproductive life, from early infancy, throughout puberty and during pregnancy until the end of the reproductive period. However, during childhood, in the absence of tonic FSH and LH stimulation, follicles cannot attain ovulatory sizes or produce significant quantities of oestrogen (Peters et al., 1978) . Puberty marks the onset of the cyclic gonadotrophin stimulation of oocytes to complete maturation, a process which includes expression of the gene programmes required for meiosis, fertilization and early cleavage. A mathematical model of follicle dynamics predicts that approximately 37 primordial follicles begin to grow every day in a 25-year-old woman and progressively decline in numbers with age until approximately zero at the menopause, which occurs at a median age of 51 years (Faddy and Gosden, 1995) (Figure 5 ).
The down-turn in fertility beginning in the fourth decade of life coincides with a significant shift in ovarian follicle dynamics. From approximately 37 years of age, the rate of primordial follicle disappearance increases 2-to 3-fold for the remaining years up to the menopause (Richardson et al., 1987; Faddy et al., 1992) . This pattern is reflected in the numbers of growing follicles and is responsible for follicle exhaustion occurring around 50 years of age rather than 20 years later had the rate of ovarian ageing not accelerated. It is still not certain whether the transition is triggered by a critical age (37 years) or by a critical number of follicles (25 000) (Faddy et al., 1992) .
Follicular growth appears to be controlled by gonadotrophins (Howe et al., 1978; Halpin et al., 1986; Ataya et al., 1989) , but they are not sufficient by themselves to initiate follicular growth because during experimental or natural hypopituitary conditions the initiation process is not completely abolished (Eshkol et al., 1970; Lintern-Moore, 1977; Howe et al., 1978; Halpin et al., 1986) . By a direct or indirect action, pituitary hormones, such as prolactin, growth hormone (GH) and thyroid stimulating hormone (TSH), may act synergistically with LH and FSH to enhance the entry of non-growing follicles into the growth phase (Howe et al., 1978) .
Early follicle growth
When the follicles enter the growth phase, they actively grow by increasing the size of the oocyte and by proliferation of GC. The mouse oocyte grows from 15 to 80 µm over a period of 2-3 weeks, whereas the human oocyte begins at 35 µm and requires several months longer to reach a final size of 120 µm (Gosden and Bownes, 1995; Gougeon, 1996) . This oocyte growth is not accompanied by reactivation of meiosis. Indeed, the dictyate chromosomes are actively synthesizing large amounts of ribosomal and mRNA, the latter being used to generate stores of proteins that are essential for later stages of oocyte maturation. The follicles progressively become multilayered and are called secondary or early growing follicles.
Over this period, the oocyte secrets glycoproteins, which condense around it to form a translucent acellular layer called the zona pellucida. The zona separates the oocyte from the surrounding GC (Takagi et al., 1989) . However, contact with the oocyte is maintained via cytoplasmic processes, which penetrate the zona and form gap junctions at the oocyte surface. Gap junctions also form in increasing numbers between adjacent GC, thus providing the basis for an extensive network of intercellular communication (Eppig, 1991 (Eppig, , 1994 Downs, 1995; Wassarman et al., 1996) .
As the follicle enlarges, a loose matrix of spindle-shaped cells develops in its inner portion adjacent to the GC. With further proliferation, the thecal cells can be distinguished as two distinct layers: an inner glandular, highly vascular theca interna, surrounded by a fibrous capsule, the theca externa. Theca cells specifically bind LH at all stages from the preantral stage of follicular development (Shima et al., 1987; Kobayashi et al., 1990) . Thus, when the theca commences its epithelioid transformation, a full responsiveness to circulating gonadotrophins is acquired by the follicle because LH and FSH receptors are present in the theca interna and granulosa and the follicle becomes directly exposed to factors circulating in the blood. From this time, the secondary follicle is defined as a 'preantral follicle' in a classification based on morphological aspect and total number of GC in each individual follicle.
Atresia
In humans, only about 400 follicles, of approximately 1-2 million healthy primordial follicles present at birth (Baker, 1963) , ovulate throughout the reproductive life. Thus, the 'normal' fate for each individual follicle is to disappear by entering a degenerative process called atresia, which must be considered as a normal process allowing the ovary to produce a specific number of ovulated mature oocytes.
A variety of hormonal changes have been hypothesized to cause atresia. Excess or insufficient gonadotrophin stimulation; excess or insufficient androgen or oestrogen production and extraovarian or intraovarian non-gonadotrophic factors, such as inhibin, gonadotrophin-releasing hormone (GnRH) -like substances and follicular regulatory proteins have all been implicated as the precipitating causes of atresia. Nevertheless, chemical messengers by themselves are probably not the only determinants of atresia. Various mechanisms, sometimes initiated by an out-of-phase gonadotrophic stimulation, such as 'inadequate' differentiation of the theca interna occurring at the preantral stage (Richards, 1980) , hypoxia (Hirshfield, 1991) , complement activation (Farookhi, 1981) or disruption of the ionic gradients (Zeleznik et al., 1989) , could be considered as mechanisms leading to atresia.
The course of follicular development from the initiation to the preovulatory stage is a long process, which implies that growing follicles are subjected to the continually changing hormone concentrations both in the peripheral blood circulation and in the ovary itself. It could be hypothesized that from the continuum of growing follicles, only those reaching a critical stage of their development, coincidental with appropriate changes in serum gonadotrophins, steroid levels, and possibly with other factors, will be spared from atresia and reach ovulation. Thus, from that hypothesis, it could be assumed that rescue of follicles 'being in the right state and place at the right time' rather than a process of 'selection' is critical for a follicle to reach ovulation. Therefore, atresia could not be assigned to a single component but to multiple mechanisms, which further act either positively or negatively regarding the stage of follicular development.
Selection of the follicle destined to ovulate
During the late luteal phase, the largest healthy follicles are between 2 and 5 mm in diameter (Gougeon and Lefevre, 1983; McNatty et al., 1983) . Their number and quality rise at this time in response to increasing peripheral FSH levels. It is among these follicles that the follicle destined to ovulate in the subsequent cycle will be selected.
The rate of atresia varies significantly during the cycle for follicles >2 mm in diameter and is inversely correlated to the circulating levels of gonadotrophins (McNatty, 1982; Gougeon, 1986) , with the highest incidence of atresia observed during mid luteal phase (McNatty et al., 1983) . The GC mitotic index of these follicles strongly increases from the mid to the late luteal phase (Gougeon, 1986) , and they are highly responsive to exogenous gonadotrophins in terms of GC proliferation (Gougeon and Testart, 1990) .
At the start of the follicular phase, the largest healthy follicle appears to be the selected follicle. Its diameter is between 5.5 and 8.2 mm (Gougeon and Lefevre, 1983) . Apart from the criteria of size and GC mitotic index, no morphological differences exist between the selected follicle and other healthy follicles. The follicle that has been selected is thought to be the one whose GC are most responsive to FSH, leading to an increase in aromatase activity in response to the inter-cycle FSH rise (Hillier, 1985) . Moreover, given the well-known promoting effect of insulin-like growth factor-1 (IGF-1) on cytodifferentiation and proliferation of GC, a speculative proposition assuming timely and selective activation of the IGF-1 system in the 'chosen' follicle has been proposed (Adashi et al., 1989) .
Maturation of the follicle destined to ovulate
In humans, the size of the preovulatory follicle greatly increases during the follicular phase by cellular multiplication and accumulation of fluid in the antrum until the ovulatory LH surge. Its diameter increases from the early to the late follicular phase from 6.9 ± 0.5 to 18.8 ± 0.5 mm (Gougeon and Lefevre, 1983) and its number of GC from approximately 2-5×10 6 to 50×10 6 (McNatty, 1982) .
During the final phase of its development, from mid follicular to ovulation, the follicle destined to ovulate is subjected to profound morphological transformations. After the mid-cycle LH surge, when mitotic figures have disappeared, as many as 1.2% pyknotic GC can be observed in human preovulatory follicles (BomselHelmreich et al., 1979) . Moreover, the fraction area of the theca layer occupied by blood vessels is significantly greater than in other follicles within the same or contralateral ovary .
From the time it has been selected, the follicle destined to ovulate shows marked changes in its steroidogenic activity, characterized by the progressive expression of all the FSHinduced activities. From the mid follicular phase, with its increased capacity to aromatize androstenedione, the follicle destined to ovulate begins to synthesize oestradiol and there is an excellent positive correlation between GC aromatase, number of GC and the concentration of oestradiol in follicular fluid (Yong et al., 1992) . Measurements in vitro of aromatase activity in GC suspensions prepared from maturing follicles have shown that its activity increases progressively during the preovulatory phase (McNatty, 1982; McNatty et al., 1983 , Hillier, 1994 .
As the follicle matures, the GC become able to bind LH (Shima et al., 1987; Kobayashi et al., 1990) . With the ovulatory LH surge, the intrafollicular concentration of oestradiol of the dominant follicle decreases, as well as that of androstenedione, whereas the levels of progesterone and its principal metabolite 17-α-hydroxyprogesterone increase sharply (Bomsel-Helmreich et al., 1979; Brailly et al., 1981; Zeleznik and Hillier, 1984) .
The expression, the 'dominant follicle' is often used to denote the follicle destined to ovulate (Hodgen, 1982) . It represents a morphological situation: the arrest in follicular development once the future ovulatory follicle commences its maturation. Hence, during the late follicular phase, most of the largest non-ovulatory follicles are atretic.
Mechanism by which a developing follicle gains dominance over other follicles
As follicles develop beyond the early antral stage under the influence of FSH, GC undergo striking developmental changes, which transform the follicle from being steroidogenically quiescent to one that is capable of producing large quantities of oestrogen. Not only does oestrogen coordinate follicle maturity and the LH surge, but also it is the principal factor that is responsible for the establishment of dominance of a maturing follicle (Hillier, 1990) .
The limiting step in follicular oestrogen biosynthesis is the acquisition of aromatase by the GC, which enables these cells to convert the thecally produced androgens into oestrogen (Hillier et al., 1995) . The induction of this enzyme is mediated by FSH (Steinkampf et al., 1987) . Thus, an early manifestation of preovulatory follicular development is the acquisition of the follicle's ability to secrete oestrogen.
There is solid experimental evidence that supports the hypothesis that the maturing follicle establishes its dominance over other follicles by feedback inhibition of FSH secretion (Vaitukaitis et al., 1971; Zeleznik, 1981; Speroff et al., 1983; Hillier, 1990) . Although the aforementioned studies are consistent with the notion that this feedback inhibition is mediated by oestrogen, it must be noted that the maturing follicle also produces the glycoprotein inhibin, which has been shown to suppress FSH secretion in both primate and subprimate model systems (Schwartz and Channing, 1971; Channing et al., 1981; Martin et al., 1988; Burger and Findlay, 1989) . Because both inhibin and oestrogen are produced as a consequence of preovulatory follicular growth, it has been difficult to establish the relative contributions of oestradiol and inhibin with respect to the suppression of FSH secretion (Lenten et al., 1991) .
Regardless of whether inhibin or oestrogen is the primary controller of FSH secretion during the follicular phase, because both are produced by the maturing follicle, the important fact is that the maturing follicle establishes its dominance over other follicles by feedback inhibition of FSH secretion.
Mechanism by which the maturing follicle maintains its dominance over other follicles
Given that: (i) FSH is required by the follicle to develop beyond the early antral stage by suppressing FSH secretion; and (ii) the development of less mature follicles is inhibited, how is it that the maturing follicle is spared from the inhibitory influences (suppression of FSH secretion) it imposes on all other follicles?
The only explanation for this phenomenon is that as the follicle matures, it becomes more sensitive to FSH such that the concentration of FSH necessary to maintain preovulatory follicular development is less than the concentration of FSH necessary to initiate preovulatory follicular development. This hypothesis was tested directly in monkeys by modulating serum FSH and LH concentrations (Zeleznik and Kubik, 1986) . These experiments demonstrated that the concentration of FSH necessary to initiate follicular growth was greater than that required to maintain preovulatory follicular growth. This provided an answer to the problem of how the selected follicle inhibited the development of less mature follicles, but did not inhibit its own growth-it became more sensitive to FSH. These data also demonstrated that there was a threshold con-centration of FSH (15-20 mIU/ml) that must be reached to initiate preovulatory follicle development. Once this threshold concentration was reached, follicles readily entered the final stages of preovulatory follicle growth and the number of follicles that reached maturity was dependent on the duration that FSH concentrations were maintained above the threshold level rather than the absolute concentration of FSH (Zeleznik and Kubik, 1986) .
Mechanisms responsible for the increased sensitivity of the maturing follicle to FSH As follicles undergo stimulation by FSH and mature to preovulatory stage, there are marked changes in the functional activity of the GC. Some of these changes contribute to the functioning of the follicle as an endocrine organ, such as the secretion of enzymes necessary for the production of oestrogen and progesterone, which are obligatory for endometrial development as well as the modulation of gonadotrophin secretion by the hypothalamic-pituitary axis. In addition to these functional changes that affect non-ovarian target organs, there are also changes in cellular functions of the FSH-stimulated follicle that have local influences on the follicular apparatus and most likely contribute to the enhanced sensitivity of the maturing follicle to FSH that is required by the follicle to maintain its dominance as plasma FSH concentrations fall. These development-dependent changes may act at different levels of follicular function and, most importantly, the contributions that each may provide to the follicle are not mutually exclusive but rather likely to provide a variety of 'fail-safe' factors that insure the maturing follicle is spared from the reduction in FSH concentrations.
Increase in FSH and LH receptors
Increases in the density of cell surface receptors serve to increase the sensitivity of target cells to the hormone. This increase in receptors should directly provide an increase in the sensitivity of the follicle to FSH because at any given concentration of FSH, more receptors are occupied in the selected follicle.
In addition to changes in number of FSH receptors on GC, a major effect of FSH on the GC is to induce cell surface receptors for LH. The presence of LH receptors on GC of developing follicles, however, could also serve to protect the follicle from the fall in plasma FSH concentrations.
Experimental evidence indicates that GC from preantral and early antral follicles possess only FSH receptors which, by acting through the cyclic adenosine monophosphate (cAMP) system, are responsible for stimulating GC differentiation function (Hillier et al., 1978; Richards et al., 1987 , Spears et al., 1998 . As a consequence of FSH stimulation, the GC acquire LH receptors, which also act through the cAMP system to stimulate GC function (Hillier et al., 1978; Richards et al., 1987) .
Although preovulatory follicles are responsive to both FSH and LH, preantral and early antral follicles are responsive only to FSH (Nayudu and Osborn, 1992; Hartshorne et al., 1994) . A reduction in FSH concentrations therefore would remove the only source of support to early antral follicles, whereas preovulatory follicles would still have the LH-mediated cAMP system available for their support and thus be spared from the fall in FSH concentrations.
Increase in capillary density
In addition to increases in hormone responsiveness, changes in the delivery of gonadotrophins to the maturing follicle could protect the follicle from a fall in FSH concentrations. It is well established that the vascularity of the follicle increases as preovulatory follicular maturation progresses and that the increase in vascularity results in preferential delivery of radiolabelled gonadotrophin to the maturing follicle . Furthermore, a new member of the heparin-binding growth factor, vascular endothelial growth factor (VEGF) has been identified and cloned (Leung et al., 1989) . This factor is a secretary protein which induces angiogenesis in vivo as well as stimulating proliferation of endothelial cells in tissue culture. A causal relationship between FSH stimulation and expression of VEGF would define a novel intraovarian mechanism by which the dominant follicle is protected from the fall in plasma FSH concentrations by developing an elaborate microvasculature that may preferentially increase its exposure to gonadotrophins.
Autocrine and paracrine regulation of follicular cell function
Over the past decade, it has become increasingly apparent that the ovary is regulated not only by the bloodborne pituitary gonadotrophins FSH and LH, but also by locally produced factors that act either on the cell that produces them (autocrine) or on neighbouring cells (paracrine) and that these factors are able to modulate the target cells responsiveness to FSH and LH directly in either a stimulatory or an inhibitory manner. The actions of these autocrine and paracrine agents could therefore serve to alter the sensitivity or responsiveness of individual follicles to FSH or LH in either a positive or a negative manner. For example, the androgens, as well as serving as substrates for conversion to oestrogens, also stimulate aromatase activity (Sanyal et al., 1974) . While oestrogens bind to receptors in the GC, which are then stimulated to proliferate and also synthesize yet more oestrogen receptors (Clark et al., 1985; McNatty, 1981; Shoham and Schachter, 1996) . As the GC are the major site for conversion of androgens to oestrogens, a system of positive feedback is operating in which oestrogen stimulates further oestrogen output (Clark et al., 1985) .
Steroids are not the only agents of paracrine activity within the follicle, as the production and activity of a number of cytokines are also stimulated by the gonadotrophins. Of particular importance are the actions of activin and inhibin (Tsonas and Sharpe, 1986) , one potential role of these compounds in the human ovary appearing to be coordination of the functional activities of the theca and the GC. Studies with isolated human thecal cells have shown that activin suppresses androgen output by the theca but stimulates the GC to develop aromatizing capacity, while inhibin stimulates androgen output and moderates aromatizing activity (Burger and Findlay, 1989; Hillier, 1991a,b) . As activin is present early in the antral phase but inhibin only later, these cytokines act to regulate the balance between androgen output and conversion. Thus, before FSH stimulation and the induction of aromatase, theca androgen production would be suppressed by activin, and excess androgen secretion would be prevented. As FSH stimulation of the follicle occurs, aromatase is induced, which would require increased production of androgen substrate. Androgen production by theca cells of the maturing follicle would be selectively increased by the production of inhibin by the neighbouring GC. Johnson and Everitt, 1990.) Additionally, a number of growth factors, including the insulin-like growth factors (Spicer et al., 1993 (Spicer et al., , 1994 , transforming growth factors (Skinner and Coffey, 1988; Roy et al., 1992) , epidermal growth factor (Das et al., 1991; Gomez et al., 1993; Merriman et al., 1998; Smitz et al., 1998) and fibroblast growth factors (Wandji et al., 1992; van Wezel et al., 1995) are expressed in the follicle and have been implicated in the regulation of follicular growth during late follicular development.
Preovulatory maturation
The onset of preovulatory maturation is marked by a sudden and dramatic rise in the release of gonadotrophins from the pituitary, especially of LH (the so-called 'LH surge'). Though both the FSH and LH levels rise, the ratio of these hormones one to the other is probably just as important in controlling preovulatory maturation as the level of LH alone. Shortly before the gonadotrophin peak, there is a sharp increase in oestrogen level and this is considered to be the stimulus for its production.
The LH surge (or the increased oestrogen that causes it) is said to induce a final 'wave' of mitosis in GC. The quantity of follicular fluid in the antrum also increases dramatically: owing to increased permeability of the blood-follicle barrier, the intrafollicular pressure initially rises in response to LH and then fluctuates before ovulation. A final and consider- Johnson and Everitt, 1990.) able increase in follicular size occurs (reaching up to 25 mm and more) almost exclusively due to a rapid expansion in the volume of follicular fluid.
In the preovulatory follicle, the fully grown immature oocyte is surrounded by several layers of GC, the cumulus oophorus (Figures 2 and 3) . The preovulatory surge of gonadotrophins stimulates two events: oocyte maturation and cumulus expansion. Oocyte maturation involves progression from prophase of the first meiotic division to metaphase of the second meiotic division (MII). The first indication of the resumption of meiosis is germinal vesicle breakdown (GVBD), which occurs about 2 h after the stimulus. The oocyte then proceeds through the first meiotic division before arresting at MII approximately 10 h later ( Figure  4 ). In addition to these cell cycle events, modifications also occur in the oocyte cytoplasm to ensure that normal fertilization can take place. These include increased concentrations of glutathione (Perreault et al., 1988) and an increased capacity for the release of intracellular calcium (Fujiwara et al., 1993; Carroll et al., 1996) .
The second LH-induced event is cumulus expansion, which involves the secretion by the cumulus cells of a hyaluronic acid-rich proteoglycan matrix (Salustri et al., 1989) . The cumulus cells disperse within the matrix which, together with a mature MII-arrested oocyte, is ovulated approximately 12 h after the LH surge.
There can be no doubt that the resumption of meiotic changes within oocytes in Graafian follicles is induced by the LH surge, but the precise mechanism is open to dispute. From studies with oocytes, zygotes and somatic cells, it is known that the cytoplasm of cells in metaphase contain a factor that can cause meiotic maturation of oocytes arrested at first meiotic prophase (Whitaker and Patel, 1990 ). The factor is referred to as meiosis-promoting factor (MPF), but since active MPF is found in metaphase of cells undergoing both meiosis and mitosis, it has also been referred to as metaphase-promoting factor. MPF activity was found to be periodic, with peak activity during metaphase and an abrupt drop in activity as a cell enters anaphase (Minshull et al., 1971) . Interestingly, small amounts of MPF can activate pre-MPF (inactive) in cells (Wasserman and Masui, 1975) .
How does MPF induce metaphase?
In summary, meiosis is driven by a MPF-kinase complex consisting of both a cyclin regulatory subunit and a catalytic subunit (p34 cdc2 ) derived from the cdk family of tyrosine kinase (Nurse, 1990; Fulka et al., 1998) . Progression through meiosis requires either or both the synthesis of cyclin B2 and its relocation from the cytoplasm to the nucleus, together with the dephosphorylation of key residues on the catalytic subunit (Naito et al., 1995) . This dephosphorylation event is catalysed by a phosphatase encoded by the cdc25 gene and is a key event in the conversion of inactive or pre-MPF into active MPF kinase (Labbe et al., 1989; Izumi and Maller, 1993) . Passage from metaphase I to anaphase occurs after proteolysis of cyclin molecules (Kobayashi et al., 1991) .
Recent interest has turned to the proto-oncogene c-mos Freeman et al., 1992) . In general, c-mos is expressed only in germ-line tissue (Hunt, 1992) . The c-mos mRNA is transcribed during the late stages of oocyte growth and increases in c-mos protein occurs only during resumption of meiosis Daar et al., 1991) . Although the mechanism by which c-mos expression leads to activation of pre-MPF is not known, studies have shown that the resumption of meiosis can be triggered by translation of c-mos mRNA or injection of c-mos protein. Furthermore, a c-mos product, Mos, is able to induce stabilization of MPF-kinase and hence arrest cell cycle progression at metaphase II; sperm penetration and resultant increases in oocyte intracellular Ca 2+ concentrations induce cyclin degradation and the completion of the meiotic cycle (Zhao et al., 1990; Daar et al., 1991; Yew et al., 1991; Hunt, 1992; Sagata, 1996 Sagata, , 1997 . 3. Reduce the cost of infertility treatment.
4. In combination with freeze-storage of immature oocytes, it could allow for oocyte banking.
5. As a research tool to investigate oocyte and follicular development.
6. Animal production science and protection of endangered species.
In-vitro oocyte and follicle culture
In-vitro maturation of mammalian oocytes has been available to the researcher since the pioneering studies of Pincus and Enzmann (1935) . They showed that oocytes liberated from unstimulated rabbit Graafian follicles undergo meiotic maturation spontaneously in vitro, as demonstrated by germinal vesicle breakdown. However, it was later shown that many of these spontaneously matured oocytes failed to be fertilized or to produce viable embryos (Thibault, 1977; Leibfried and Bavister, 1983; Shalgi, 1984; Fleming et al., 1985; Bavister, 1987) . In many cases, by supplementing the culture medium with gonadotrophins and/or hormones, spontaneously matured oocytes could be fertilized and undergo cleavage. The development of these novel techniques for the culture of murine oocytes has raised the possibility of growing human oocytes to maturity in vitro. The evolution of such a system holds the key to a number of techniques with revolutionary consequences (Table II) . It would clearly be of benefit in basic physiological studies of follicular development, as well as being used to test the effect of toxicological substances on oocyte maturation. More significantly, such a system could provide a source of human oocytes for in-vitro fertilization (IVF) where immature or germinal vesicle oocytes are cultured to maturity before being fertilized. If this can be achieved, it might open the door to oocyte cryopreservation, where surplus oocytes are stored, thus avoiding the need for repeated superovulation. A combination of immature oocyte cryopreservation for later maturation and IVF will provide the opportunity to establish oocyte banks and help overcome some of the practical and ethical dilemmas that are currently shadowing the field of reproductive medicine. Among the many other benefits of in-vitro maturation is that the need for gonadotrophin stimulation of the ovary would be minimized and might even become redundant, hence reducing the cost of IVF treatment. Furthermore, by avoiding gonadotrophin treatment, patients with polycystic ovarian syndrome may avoid the serious risk of ovarian hyperstimulation syndrome.
Oocyte versus follicle culture
Various systems have been devised for studies of either oocyte or follicle development (Tables III and IV) . These involves two overlapping strategies ( Figure 5 ): (i) In-vitro maturation (IVM), in which fully grown oocytes are collected from unstimulated Graafian follicles. Under appropriate conditions, oocytes at the germinal vesicle stage recommence meiosis and reach metaphase II in 24-48 h, when they are ready for insemination; and (ii) In-vitro growth (IVG) in which follicles at the primordial or preantral stages are obtained from ovarian biopsies. Oocytes have to grow to full size in culture before they are able to undergo IVM and become fertilized.
In-vitro oocyte maturation (IVM)
A number of systems have been developed whereby oocytes from immature follicles can be grown to full maturity in vitro ( Figure 6 ). Immature mouse oocytes contained in granulosaoocyte complexes can be grown on collagen-coated membranes (Eppig and Schroeder, 1989) , or whole, individual preantral follicles can be developed to Graafian stage (Nayudu and Osborn, 1992,) and subsequently ovulated (Boland et al., 1993) . Oocytes obtained at the end of either system can be fertilized, and live young obtained (Eppig and Schroeder, 1989; Spears et al., 1994) . Oocyte-granulosa cell complexes isolated from preantral follicles of both the rat (Daniel et al., 1989) and pig (Hirao et al., 1994) have also been cultured. Rat complexes were cultured directly on culture dishes, whereas pig complexes were cultured within collagen gels. In both cases, oocytes grew in culture and acquired competence to undergo maturation. Some of the rat oocytes underwent fertilization and cleavage to the 2-cell stage before development was arrested (Daniel et al., 1989) . Although some of the mature pig oocytes were penetrated by spermatozoa, male pronuclear development failed to occur (Hirao et al., 1994) . Oocytes isolated from preantral follicles and cultured denuded of GC either alone or in co-culture with GC do not undergo significant growth (Eppig, 1977 (Eppig, , 1979 , but oocytes cultured with intact gap junctions between the oocytes and the GC grow and become competent to undergo nuclear maturation (Eppig, 1977; Daniel et al., 1989; Hirao et al., 1990 Hirao et al., , 1994 . Hence, one of the major objectives in the development of an oocyte culture system is to restrict migration of GC away from the oocyte since, as described earlier, the association of these cells with the oocyte is essential for oocyte growth and development. This problem was resolved by either using a collagen-impregnated membrane or serum-coated dishes, combined with the elimination of serum from the culture medium (Eppig and Schroeder, 1989) . Alternatively, the oocyte-granulosa cell complexes could be embedded completely within a collagen matrix (Torrance et al., 1989; Hirao et al., 1994) . In-vitro follicle growth (IVG)
As described earlier, initiation of follicle growth involves the passage of primordial follicles from quiescent phase and is characterized by three main events: change in shape of the GC from squamous to cuboidal, proliferation of GC, and oocyte enlargement (Hirshfield, 1991) . Oocyte development and, therefore, the culture systems that have been described previously (Daniel et al., 1989; Eppig and Schroeder, 1989; Torrance et al., 1989; Eppig et al., 1990 Eppig et al., , 1992a Carroll et al., 1991; Hirao et al., 1994) are very different from the culture systems adopted for primordial follicle growth. The ideal culture system would allow development of follicles from primordial to Graafian stage, an aim that has recently been achieved in the mouse (Eppig and O'Brien, 1996) . This was possible by culturing primordial follicles through the earliest stages of development as organ explants for 8 days, followed by isolation and culture as granulosa-oocyte complexes for a further 14 days. The total period of development of approximately 3 weeks corresponds to the full span of growth in vivo. The equivalent achievement with human primordial follicles will require a much longer period-probably in excess of 6 months (Gougeon, 1986 )-as the difference in growth rates between large and small mammals is even more marked during the sluggish, early preantral growth. Nevertheless, these results clearly show that complete development of oocytes in vitro from the primordial stage is possible and establish the framework for further studies on the complex interactions of oocytes and their companion somatic cells and the role of various endocrine, paracrine and autocrine factors in promoting the development of both the oocyte and the GC together. Indeed, activation of primordial follicular growth in vitro has been achieved in cattle (Wandji et al., 1996; Braw-Tal and Yossefi, 1997) and baboon (Wandji et al., 1997) . All of these studies have demonstrated that a high percentage of primordial follicles in cortical pieces from fetal or adult mammalian ovaries are capable of initiating growth and development in vitro in serum-free medium. Furthermore, human primordial follicles were also found to proliferate up to secondary follicles in vitro, even after freeze-storage (Hovatta et al., 1997) . More recently, human primordial follicles were shown to survive and grow to antral-secretory stages when grafted under the renal capsule of immunodeficient mice for 17 weeks (Oktay et al., 1998) .
Enzymatic versus manual isolation
Preantral follicles can be isolated using collagenase digestion (Roy and Greenwald, 1989; Roy and Treacy, 1993) or by disaggregation under a stereomicroscope using fine needles (Cortvrindt et al., 1996; Abir et al., 1997) or by a combination of both (Torrance et al., 1989; Oktay et al., 1997) .
Enzymatic digestion yields oocyte-granulosa cell complexes comprised of an oocyte surrounded by one to three layers of GC. The proteolytic treatment removes most, if not all, the theca layers and degrades the basal lamina. This enzymatic isolation can be advantageous since it eliminates layers of cells that would normally be vascularized and therefore present a barrier to diffusion of dissolved gases and metabolites. Evidently, theca cells are not as mandatory as the GC for the development of the oocyte, though necessary for normal steroidogenesis (Gilling-Smith et al., 1994; Gougeon, 1996) . Manual dissection on the other hand, is more laborious but it avoids chemical damage to cells and follicles. Furthermore, it has been shown recently by Abir et al. (1997) that human preantral and small antral follicles can be isolated manually without the need for enzymatic digestion, while Oktay et al. (1997) isolated human primordial follicles from fresh and frozen-thawed ovarian tissue by a combination of an enzymatic digestion and manual dissection. Alternatively, it may be possible that isolation of primary and primordial follicles may not be necessary for in-vitro growth, since mouse primary follicles have been cultured in groups following manual dissection and follicles reached the preovulatory stages (Qvist et al., 1990) .
Culture medium
There is little information on the best culture conditions for maturation and fertilization of immature human oocytes. A variety of culture media has been used, though Minimal Essential Medium (MEM) and M199 have often been adopted because they were effective in animal studies (Spears et al., 1994) . Since an important role of the cumulus cells is to provide nutritional support to the developing oocyte (Buccione et al., 1990; Haekwon and Schuetz, 1991 ) the development of a culture medium which supports normal GC functions is therefore likely to provide a suitable environment for oocyte maturation. Listed below are some of the additives to the culture medium.
Gonadotrophins
Several studies have shown that gonadotrophic hormones are not essential for the initiation of follicle growth in mice (Eshkol et al., 1970; Ryle, 1972; Peters et al., 1973) , rats (Nakano et al., 1975; Hirschfield, 1985; Cain et al., 1995 ), sheep (McNatty et al., 1990 and cattle (Braw-Tal and Yossefi, 1997; Wandji et al., 1997) since primordial follicles were noted to commence follicular growth in the absence of gonadotrophins. This might be due to the fact that primordial follicles lack FSH receptors, which first appear in GC during the primary stage (Richards and Midgley, 1976; Wandji et al., 1992; Tisdall et al., 1995) . Although gonadotrophins may not be required to initiate follicular growth, it is clear that FSH is necessary to maintain follicular development, cumulus expansion and oocyte maturation. This has been documented in a number of species, including mouse (Eppig and Schroeder, 1989; Jinno et al., 1990) , rat (Mannaerts et al., 1994) and human (Gomez et al., 1993) .
The overriding importance of FSH during follicle development was elegantly demonstrated by Spears et al. (1998) who showed that, in the absence of FSH, mouse follicles were unable to develop and degenerated at the stage when antrum formation was incipient. Furthermore, mouse embryos developed from oocytes matured in the presence of FSH were shown to develop to late-stage fetuses at rates similar to in-vivo-matured controls (Merriman et al., 1998) . On the other hand, only trace quantities of LH are required to stimulate the production of androgens by theca cells which are subsequently aromatized in the GC under the influence of FSH (Karnitis et al., 1994; Balasch et al., 1995; Cortvrindt et al., 1996) . Hence, while FSH is paramount in maintaining follicular development, LH plays a little role beyond increasing the production of oestrogen.
Epidermal growth factor (EGF)
Work done by Downs et al. (1988) and Downs (1989) on mouse cumulus complexes and by Dekel and Sherizly (1985) on explanted rat follicles pointed to a very effective stimulatory action by EGF on cumulus expansion and GVBD via the generation of a positive stimulus originating from cumulus cells. However, EGF on its own was found to be incapable of completely overruling the inhibitory signals from the somatic cells (Smitz et al., 1998) . On the other hand, when combined with human chorionic gonadotrophin (HCG), doses of EGF ≥5 ng/ml significantly stimulated the transition of mouse follicle-enclosed oocytes from MI to MII, while maximum rates of cumulus expansion and nuclear maturation in bovine oocytes were obtained when EGF was combined with IGF-I (Lorenzo et al., 1994) . Furthermore, EGF together with FSH improved the rate of fertilization of in-vitro-matured mouse oocytes (Merriman et al., 1998) . Thus, EGF, either alone, but possibly in combination with other factors, seems to have a positive influence on cumulus expansion and meiotic maturation of in-vitro-matured oocytes.
Serum?
By far the most critical component which can influence the success of IVM is supplementation of the culture medium with serum (Trounson et al., 1994a; Russell et al., 1997) or follicular fluid (Cha et al., 1991) . Historically, monolayers of GC cultured in the presence of serum have been used to investigate the effects of hormonal treatments on steroidogenesis (Erickson et al., 1979; Ham and McKeehan, 1979) . While the inclusion of serum provides a complex mixture of hormones, nutrients, growth and attachment factors (including collagen and fibronectin) which are necessary to support cell proliferation, serum also exerts inhibitory effects on follicular-type functions of GC. In addition, serum contains many kinds of components, such as proteins, amino acids, carbohydrates, trace elements, hormones, growth factors, cell attachment and spreading factors and some, as yet, unidentified factors. Typically, rat and human GC cultured in the presence of serum or extracellular matrix proteins (Furman et al., 1986; Amsterdam and Rotmensch, 1987) rapidly proliferate to form flattened, epithelioid monolayers with a dramatically different morphology to that seen in vivo. Furthermore, in the presence of serum, cells spontaneously luteinize and lose their capacity to convert androgens to oestrogens. For these reasons, the reduction in the number of undefined components of the culture system is essential in resolving the mechanisms governing oocyte growth and development.
Optimization of the novel serum-free culture system, developed for ovine (Campbell et al., 1996) , bovine (Gutierrez et al., 1997) and porcine GC (Picton et al., 1994) to support IVM of oocytes offers major advantage over serum-based systems. Using this approach it is possible to maintain oestradiol production in GC which are exquisitely sensitive to physiological concentrations of gonadotrophins. The combination of suitable concentrations of EGF and IGF-1 have well-established effects on GC and stimulate mucification (Das et al., 1992; Lorenzo et al., 1994) . Using this serum-free approach, cultured GC form distinct clumps of rounded cells (Picton et al., 1994; Campbell et al., 1996; Gutierrez et al., 1997) which morphologically resemble GC in vivo (Chang, 1977) . In response to FSH and insulin (Amsterdam et al., 1988) in the culture medium, the extensive network of gap junctions between cumulus cells and the oocyte is maintained. Following exposure to high levels of FSH and LH in vitro, the controlled luteinization of cumulus cells and paracrine signalling breaks these fragile connections and hence aids the resumption of nuclear maturation in the oocyte. In contrast, cell proliferation and attachment to the culture surface, caused by inclusion of serum and attachment factors in the incubation media, may lead to premature disruption of oocyte-cumulus communication and so compromise oocyte maturation potential.
While a chemically defined culture system allows the study of energy metabolism and endocrine function of the oocyte, prolonged culture in the absence of serum may have undesirable side effects on the oocyte such as premature cortical granule release that leads to hardening of the zona pellucida which would reduce the fertilization potential of the oocyte (Eppig et al., 1992a,b; Green, 1997) . Additionally, zona hardening has been shown to reduce the rate of blastocyst hatching in the rhesus monkey from 77% in serum-based medium to only 25% in serum-free culture (Schramm and Bavister, 1996) . Although 'zona hardening' has never been quantified in human IVM oocytes, approaches to minimize its impact, such as fertilization with intracytoplasmic sperm injection (ICSI) followed by assisted hatching has been successfully applied to human IVM oocytes (Barnes et al., 1995) . Ultimately, it may prove necessary to perform both ICSI and assisted hatching for all IVM oocytes and embryos. Or, alternatively, with adaptations to the culture medium such as the addition of the serum-derived antioxidant fetuin, one might be able to overcome the potential problem of zona hardening .
Supplemental factors
Insulin and insulin-like growth factors have been shown to enhance the response of ovarian cells to gonadotrophins (Guidice, 1992; Adashi, 1993; Magoffin and Weitsman, 1993) . Roy and Greenwald (1989) as well as Cain et al. (1995) have emphasized the importance of the addition of insulin from the beginning of culture of preantral follicles to support follicular viability. However, insulin alone could not maintain the health of the follicles, and other supplemental factors are needed.
Transferrin, another supplemental factor used in culture media, has no obvious effect on the growth or function of cells, but can protect the cells by acting as a chelator of contaminating toxic metals or as a competitive substrate for proteolytic enzymes released by the cells into the medium (Orly et al., 1980; Cain et al., 1995) . Hydrocortisone, the third supplemental factor used in culture media, is not essential for growth, but it has been shown to sustain steroidogenesis (Orly et al., 1980) .
Pregnancies from IVM human oocytes
The first viable pregnancy based on IVM oocytes was reported from Seoul, Korea in 1991 (Cha et al., 1991) . Oocytes were collected from 2 to 5 mm follicles in ovaries donated by patients undergoing gynaecological surgery. After incubation in medium for 32-48 h, they were fertilized and cultured for a further 48 h. Five embryos were transferred to a woman with premature ovarian failure who was receiving steroid supplementation for endometrial priming, and who later delivered healthy triplet daughters. Since then, few more babies have been born from in-vitromatured human prophase I oocytes (Trounson et al., 1994b; Barnes et al., 1995; Nagy et al., 1996; Edirisinghe et al., 1997; Jaroudi et al., 1997; Russell et al., 1997) . Oocytes from human menopausal gonadotrophin (HMG)-stimulated cycles showed a significantly higher maturation rate than those from unstimulated cycles, but no information has been provided on their ability to become fertilized (Gomez et al., 1993) . Moreover, Barnes et al. (1996) reported that oocytes from regularly cycling women have a better developmental capability than those from irregularly cycling and anovulatory women.
Conclusions and future prospects
The investigation of oocyte development is driven not only by scientific curiosity of a remarkable cell, but also by a practical need to understand the oocyte's developmental biology and the dynamics of formation, utilization and wastage. Not only will we gain an appreciation of the complex interactions of factors leading to the development of normal ova, but studies of oocyte development in vitro could identify specific molecules produced during oocyte development that are essential for normal early embryogenesis and perhaps identify defects leading to infertility or abnormalities in embryonic development. Although the success rates for immature oocyte recovery followed by in-vitro oocyte maturation are still poor, it is a promising new technology for the treatment of human infertility. It is attractive to potential oocyte donors and infertile couple because of its reduced treatment intervention which results in substantial cost savings in fertility drugs and patient monitoring. With much investigation needed, the prospect of growing human oocytes to maturity in vitro is still some way off (Trounson et al., 1996) . However, the potential benefits of such a technique certainly warrants continued investigation to shed some light on the intriguing aspects in the life cycle of the mammalian oocyte. Such achievements could not only revolutionize assisted conception, but also have a large impact on farm animal production and even conservation of endangered species and rare breeds.
